FIDCX | RYKIX | FIDCX / RYKIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 27 years | - |
Gain YTD | 2.785 | 3.537 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 428M | 29.5M | 1,451% |
Annual Yield % from dividends | 1.22 | 1.40 | 87% |
Returns for 1 year | 15.71 | 31.79 | 49% |
Returns for 3 years | -5.64 | 5.71 | -99% |
Returns for 5 years | -8.93 | 40.23 | -22% |
Returns for 10 years | -0.62 | 90.77 | -1% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMCX | 12.47 | -0.04 | -0.32% |
Columbia Emerging Markets C | |||
LYFCX | 12.87 | -0.05 | -0.39% |
AlphaCentric Life Sciences & Hlthcare C | |||
TRTIX | 18.26 | -0.10 | -0.54% |
T. Rowe Price International Value Eq I | |||
AUENX | 21.13 | -0.16 | -0.75% |
AQR Large Cap Defensive Style N | |||
ACUSX | 12.65 | -0.17 | -1.33% |
Advisors Capital Total Return – Equity |